What is the appropriate gabapentin dosing regimen for treating orthostatic tremor, including titration schedule, maximum dose, and adjustments for impaired renal function?

Gabapentin Dosing for Orthostatic Tremor

For orthostatic tremor, initiate gabapentin at 300 mg three times daily and titrate upward by 300 mg every 1-7 days as tolerated, targeting an effective dose range of 600-2,700 mg/day divided three times daily, with most patients responding to 900-1,800 mg/day. 1, 2

Starting Dose and Titration Schedule

Begin with 300 mg three times daily (or 300 mg at bedtime if tolerability is a concern). Increase by 300 mg increments every 1-7 days based on symptom response and tolerability 1, 2. The FDA-approved titration for gabapentin allows increases of 100-300 mg every 1-7 days 3, but orthostatic tremor studies specifically used 300 mg increments.

Key titration principle: Gabapentin has nonlinear pharmacokinetics due to saturable absorption, requiring careful dose escalation to optimize both efficacy and tolerability 4.

Target Therapeutic Dose

• Effective dose range: 600-2,700 mg/day in divided doses (three times daily) 1
• Most common effective dose: 900-1,800 mg/day 2, 5
• Mean effective dose in clinical studies: Approximately 1,030 mg/day 2

Clinical response typically includes 50-75% symptom reduction with improvements in tremor amplitude, postural stability, and quality of life 1, 5. Maximum time between doses should not exceed 12 hours 3.

Maximum Dose

While the FDA label permits up to 3,600 mg/day in three divided doses for other indications 3, orthostatic tremor studies have demonstrated efficacy at lower doses. One study used up to 2,400 mg/day 6, and another reported a maximum of 2,700 mg/day 1. Most patients achieve adequate symptom control at 1,800 mg/day or less 1, 2.

Renal Dose Adjustments

Gabapentin requires mandatory dose reduction in renal impairment because it is exclusively renally cleared without hepatic metabolism 3, 7. Adjust based on creatinine clearance (CrCl):

Dosing by Renal Function 3:

• CrCl ≥60 mL/min: 300-1,200 mg three times daily (standard dosing)
• CrCl 30-59 mL/min: 200-700 mg twice daily
• CrCl 15-29 mL/min: 200-700 mg once daily
• CrCl <15 mL/min: 100-300 mg once daily
• Hemodialysis patients: Maintenance dose based on CrCl plus supplemental 125-350 mg post-dialysis

Critical caveat: Elderly patients frequently have reduced renal function despite normal serum creatinine due to decreased muscle mass. Always calculate CrCl using the Cockcroft-Gault equation before dosing 3. Apparent oral clearance decreases from ~225 mL/min in patients <30 years to ~125 mL/min in those >70 years 3.

Practical Dosing Algorithm

1. Calculate baseline CrCl to determine if renal adjustment needed
2. Start 300 mg TID (or 300 mg QHS if concerned about tolerability)
3. Increase by 300 mg every 3-7 days as tolerated
4. Target 900-1,800 mg/day divided TID
5. Assess response at 2-4 weeks after reaching target dose
6. Maximum trial duration: 3-8 weeks for titration plus 2 weeks at maximum tolerated dose 4

Common Pitfalls

• Dose-dependent dizziness and sedation are the primary adverse effects—mitigate by starting low and titrating slowly 4
• Forgetting renal adjustment: Failure to reduce dose in renal impairment leads to drug accumulation and increased adverse effects 7
• Inadequate trial duration: Allow sufficient time (up to 2 months) to reach therapeutic dose and assess response 4
• Abrupt discontinuation: Taper gradually over minimum 1 week if stopping 3

Evidence Quality Note

The orthostatic tremor evidence base consists primarily of small case series and one double-blind crossover study (n=6) 1. However, gabapentin consistently demonstrates 50-75% symptom reduction across multiple studies 1, 2, 6, 5, with sustained benefit over 11-22 months 2. A recent 2025 systematic review supports gabapentin as a treatment option, though notes perampanel and clonazepam may have higher efficacy 8.